%0 Journal Article
%T Model funkcjonalny HB-HTA z koordynującą rolą Regionalnego Centrum Oceny Inwestycji wspartego przez Narodowy Fundusz Zdrowia oraz Agencję Oceny Technologii Medycznych i Taryfikacji – model mieszany
%A Gałązka-Sobotka, Małgorzata
%A Kowalska-Bobko, Iwona
%J Zdrowie Publiczne i Zarządzanie
%V 2020
%R 10.4467/20842627OZ.20.033.14277
%N Tom 18, Numer 4
%P 298-309
%K HB-HTA, lecznictwo szpitalne, ocena technologii medycznych, płatnik, szpitalna ocena technologii medycznych, szpital, technologia medyczna, władze regionalne, zarządzanie ochroną zdrowia; health care management, health technology, Health Technology Assessment, Hospital-Based Health Technology Assessment, hospital, hospital treatment, payer, regional health departments
%@ 1731-7398
%D 2021
%U https://ejournals.eu/czasopismo/zdrowie-publiczne-i-zarzadzanie/artykul/model-funkcjonalny-hb-hta-z-koordynujaca-rola-regionalnego-centrum-oceny-inwestycji-wspartego-przez-narodowy-fundusz-zdrowia-oraz-agencje-oceny-technologii-medycznych-i-taryfikacji-model-mieszany
%X 
	Mixed functional model HB-HTA with the coordinating role of the Regional Center for Investments supported by the Polish National Fund and Agency for Health Technology Assessment and Tariff System 

	The implementation of the strategic model for hospital health technology assessment in Poland requires the involvement of many stakeholders. HB-HTA fundamentally concerns hospitals and how they rationalize decision making in implementing innovative medical technologies. However, the need to obtain public funding after verifying the effectiveness of a given medical technology or to keep up with the evolving HB-HTA method­ology naturally requires the involvement of both the payer (NFZ) and the Agency for Health Technology Assessment and Tariff System in activities connected with the implementation and development of HB-HTA. An important aspect of the coordination of activities in relation to hospital HTA is also the support given to hospitals by regional authorities – competent health departments in voivodeship offices – by assessing HB-HTA reports prepared by the hospitals and indicating regional competitive potential of a given medical technology. This creates a hybrid/mixed system of insti­tutional support for innovative medical technologies implemented in hospitals.

	This institutional plurality within HB-HTA is a clear asset, strengthening the hospital’s planned undertaking substantively and financially, especially when the assistance mechanisms undertaken are flexible, soft in nature, and allow hospital units to shape effective HB-HTA activities.